Treatment and Control Methods of Bovine Mastitis: A Review
DOI:
https://doi.org/10.17140/vmoj-9-182Keywords:
Bovine; Control; Methods; Treatment; Mastitis.Abstract
The goal of this review is to summarize various approaches to treat and control bovine mastitis. Bovine mastitis, often known as udder inflammation, has various causes. The primary treatment for mastitis is intramammary infusion. However, antibiotic resistance
mechanisms have emerged, posing a risk to global health today. Given the broad rise of antibiotic resistance, novel drugs to treat
and prevent the disease are urgently required. As a result, novel treatment and control methods arose, including the use of animalderived compounds, bacteriophage therapy, probiotics, herbal therapy, immunotherapy, nanoparticle-based therapy, and sonic pulse
therapy. Control measures include immunization, hygiene, feeding management, and dry cow therapy. Bee products have recently
replaced animal-derived compounds as a treatment for cattle mastitis. Probiotics, on the other hand, may work by modifying gut
flora, with evidence supporting their direct influence on mastitis in dairy cows. In contrast, a proprietary Acoustic Pulse Therapy
(APT) device was designed specifically for treating dairy cows. However, its usefulness in veterinary medicine is limited. Vaccines
can help prevent mastitis, alleviate clinical symptoms, and accelerate the healing process. Vaccination boosts acquired immunity to
a specific pathogen and has few side effects; nevertheless, because to the wide range of mastitis-causing organisms, particularly
emerging environmental infections, vaccine treatment of mastitis presents significant challenges. A proper milking hygiene program
that meets all of the dairy cow's biological and hygienic requirements has a significant impact on udder health. Vitamins, probiotics,
and other feed additives can help improve udder health, cow immunity, and general body condition. Dry cow therapy is an intramammary or systemic antibiotic treatment for the udder administered during the dry season. Cows with clinical or subclinical illnesses
should be treated with non-antibiotic antimicrobial agents.
References
Abera A, Review on the prevalence and associated risk factors of bovine mastitis in lactating cows of smallholder dairy farms in Ethiopia. Journal of Medical Research and Health Sciences. 2020; 3(5). doi: 10.15520/jmrhs.v3i5.177
Hailay T, Gugsa G, Awol N, Tsegaye Y, Ahmed M. Bovine mastitis: Prevalence and antimicrobial patterns of Staphylococ-cus aureus and Escherichia coli in smallholder dairy farms of Adawa and Enticho Towns, Tigray, Ethiopia. 2023. doi: 10.21203/ rs.3.rs-3075985/v1
Cervinkova D, Vlkova H, Borodacova I, et al. Prevalence of mastitis pathogens in milk from clinically healthy cows. Vet Med. 2013; 58(11): 567-575.
Kibebew K, Bovine mastitis: A review of causes and epidemio-logical point of view. Journal of Biology, Agriculture and Healthcare. 2017; 7(2): 1-14.
Leitner G, Zilberman D, Papirov E. Shefy S, Assessment of acoustic pulse therapy (APT), a non-antibiotic treatment for dairy cows with clinical and subclinical mastitis. PLoS One. 2018; 13(7): e0199195. doi: 10.1371/journal.pone.0199195
Rainard P, Foucras G. A critical appraisal of probiotics for masti-tis control. Front Vet Sci. 2018; 5: 251. doi: 10.3389/fvets.2018.00251
Adane B, Gizaw Y, Amde B. Prevalence of bovine mastitis and isolation of causative major pathogens in and around Jigjiga, So-mali Region, Ethiopia. European Journal of Applied Sciences. 2017; 9(6): 287-295. doi: 10.5829/idosi.ejas.2017.287.295
Pokharel S, Shrestha P, Adhikari B. Antimicrobial use in food animals and human health: time to implement ‘One Health’ ap-proach. Antimicrobial Resistance & Infection Control. 2020; 9: 81. doi: 10.1186/s13756-020-00847-x
Sharun K, Dhama K, Tiwari R, et al. Advances in thera-peutic and managemental approaches of bovine mastitis: A comprehensive review. Vet Q. 2021; 41(1): 107-136. doi:
1080/01652176.2021.1882713 10. Cheng WN, Han SG. Bovine mastitis: risk factors, therapeutic strategies, and alternative treatments - A review. Asian-Australas J Anim Sci. 2020; 33(11): 1699-1713. doi: 10.5713/ajas.20.0156
Yang WT, Ke CY, Wu WT, Lee RP, Tseng YH. Effective treat-ment of bovine mastitis with an intramammary infusion of Angel-ica dahurica and Rheum officinale extracts. Evid Based Complement Alternat Med. 2019: 2019: 7242705. doi: 10.1155/2019/7242705
Hossain MK, Paul S, Hossain MM, Islam MR, Alam MG. Bo-vine mastitis and its therapeutic strategy by doing an antibiotic sensitivity test. Austin J Vet Sci Anim Husb. 2017; 4(1): 1030. doi: 10.26420/AUSTINJVETSCIANIMHUSB.2017.1030
Burović J. Isolation of bovine clinical mastitis bacterial patho-gens and their antimicrobial susceptibility in the Zenica region in 2017. Veterinarska stanica. 2020; 51(1): 47-52. doi: 10.46419/ vs.51.1.5
Fuenzalida MJ, Ruegg PL. Negatively controlled, randomized clinical trial to evaluate intramammary treatment of nonsevere, gram-negative clinical mastitis. J Dairy Sci. 2019; 102(6): 5438-5457. doi: 10.3168/jds.2018-16156
Suojala L, Kaartinen L, Pyörälä S. Treatment for bovine Esch-erichia coli mastitis–an evidence-based approach. J Vet Pharmacol Ther. 2013; 36(6): 521-531. doi: 10.1111/jvp.12057
Ruegg PL. What is success? A narrative review of research eval-uating outcomes of antibiotics used for treatment of clinical masti-tis. Front Vet Sci. 2021; 8: 639641. doi: 10.3389/fvets.2021.639641
Verma H, Rawat S, Sharma N, Jaiswal V, Singh R, Harshit V. Prevalence, bacterial etiology and antibiotic susceptibility pattern of bovine mastitis in Meerut. J. Entomol. Zool. Stud. 2018; 6(1): 706- 709.
Jeong CH, Cheng WN, Bae H, et al. Bee venom decreases LPS-induced inflammatory responses in bovine mammary epithelial cells. J. Microbiol. Biotechnol. 2017; 27(10): 1827-1836. doi: 10.4014/ jmb.1706.06003
Gomes F, Henriques M. Control of bovine mastitis: Old and recent therapeutic approaches. Current Microbiology. 2016; 72: 377- Review | Volume 9 | Issue 1 | Kebede IA, et al 382. doi: 10.1007/s00284-015-0958-8
Kutila T, Pyörälä S, Kaartinen L, et al. Lactoferrin and citrate concentrations at drying-off and during early mammary involution of dairy cows. Journal of Veterinary Medicine Series A. 2003; 50(7): 350-353. doi: 10.1046/j.1439-0442.2003.00560.x
Nale JY, McEwan NR. Bacteriophage therapy to control bo-vine mastitis: A review. Antibiotics. 2023; 12(8): 1307. doi: 10.3390/ antibiotics12081307
Qolbaini EN, Khoeri MM, Salsabila K, et al. Identification and antimicrobial susceptibility of methicillin-resistant Staphylo-coccus aureus-associated subclinical mastitis isolated from dairy cows in Bogor, Indonesia. Vet World. 2021; 14(5): 1180 -1184. doi: 10.14202/vetworld.2021.1180-1184
Pellegrino MS, Frola ID, Natanael B, Gobelli D, Nader-Macias ME, Bogni CI. In vitro characterization of lactic acid bacteria iso-lated from bovine milk as potential probiotic strains to prevent bovine mastitis. Probiotics Antimicrob Proteins. 2019; 11: 74-84. doi: 10.1007/s12602-017-9383-6
Kober AH, Saha S, Islam MA, et al. Immunomodulatory ef-fects of probiotics: A novel preventive approach for the control of bovine mastitis. Microorganisms. 2022; 10(11): 2255. doi: 10.3390/ microorganisms10112255
Ajose DJ, Oluwarinde BO, Abolarinwa TO, et al. Combat-ing bovine mastitis in the dairy sector in an era of antimicrobial resistance: Ethno-veterinary medicinal option as a viable alter-native approach. Front Vet Sci. 2022; 9: 800322. doi: 10.3389/ fvets.2022.800322
Tomanić D, Kladar N, Radinović M, et al. Intramammary eth-no-veterinary formulation in bovine mastitis treatment for optimi-zation of antibiotic use. Pathogens. 2023; 12(2): 259. doi: 10.3390/ pathogens12020259
Nayak R, Chauhan M, Raut ST, Paik GR, Kumar A, Ku-mar S. Treatment of bovine mastitis by using ethnoveteri-nary herbal medicine. Medico-Biowealth of India. 2021; Vol. III.: 8.Website.https://www.researchgate.net/profile/SanjeetKu-mar16/publication/357312556_Medico_Bio-wealth_of_India/ links/61c60fc0b8305f7c4bfb5845/Medico-Bio-wealth-ofIndia. pdf#page=15. Accessed January 30, 2024.
Leitner G, Pinchasov Y, Morag E, et al. Immunotherapy of mastitis. Vet Immunol Immunopathol. 2013; 153(3-4): 209-216. doi: 10.1016/j.vetimm.2013.02.017
McDougall S, Abbeloos E, Piepers S, et al. Addition of meloxi-cam to the treatment of clinical mastitis improves subsequent re-productive performance. J Dairy Sci. 2016; 99(3): 2026-2042. doi: 10.3168/jds.2015-9615
Neculai-Valeanu AS, Ariton AM, Mădescu BM, Rîmbu CM, Creangă Ş. Nanomaterials and essential oils as candidates for devel-oping novel treatment options for bovine mastitis. Animals (Basel). 2021; 11(6): 1625. doi: 10.3390/ani11061625
Kalińska A, Jaworski S, Wierzbicki M, Gołębiewski M. Silver and copper nanoparticles—an alternative in future mastitis treat-ment and prevention? Int J Mol Sci. 2019; 20(7): 1672. doi: 10.3390/ ijms20071672
Ren G, Hu D, Cheng EW, Vargas-Reus MA, Reip P, Allaker RP. Characterization of copper oxide nanoparticles for antimicro-bial applications. Int J Antimicrob Agents. 2009; 33(6): 587-590. doi: 10.1016/j.ijantimicag.2008.12.004
Prakash V, Rathaur A, Rai DC, Singh SJ. Role of nanotechnol-ogy in mastitis treatment for dairy cows: A mini-review: Letters In Animal Biology. 2022; 2(2): 29-34. doi: 10.62310/liab.v2i2.95
Dego OK, Aral F, Payan-Carreira R, Cuaresma M. Control and prevention of mastitis: part two. Anim Reprod Vet Med. 2020; 27: 1-1. doi: 10.5772/intechopen.93484
Merrill C, Ensermu DB, Abdi RD, et al. Immunological respons-es and evaluation of the protection in dairy cows vaccinated with staphylococcal surface proteins. Veterinary Immunology and Immuno-pathology. 2019; 214: 109890. doi: 10.1016/j.vetimm.2019.109890
Collado R, Prenafeta A, González-González L, Pérez-Pons JA, Sitjà M. Probing vaccine antigens against bovine mastitis caused by Streptococcus uberis. Vaccine. 2016; 34(33): 3848-3854. doi: 10.1016/j.vaccine.2016.05.044
Zhylkaidar A, Oryntaev K, Altenov A, Kylpybai E, Chayxmet E. Prevention of bovine mastitis through vaccination. Arch Razi Inst. 2021; 76(5): 1381-1387. doi: 10.22092/ari.2021.356008.1764
Webster J. Understanding the Dairy Cow. NY, USA: John Wiley & Sons; 2020.
Zigo F, Vasil’ M, Ondrašovičová S, Výrostková J, Bujok J, Pecka-Kielb E. Maintaining optimal mammary gland health and Submit your article to this journal | https://openventio.org/online-manuscript-submission-system/ prevention of mastitis. Front Vet Sci. 2021; 8: 607311. doi: 10.3389/ fvets.2021.607311
Iraguha B. Bovine mastitis control strategies with emphasis on developing countries. IntechOpen. 2023. doi: 10.5772/intecho-pen.112348
Kerr DE, Wellnitz O. Mammary expression of new genes to combat mastitis. J Anim Sci. 2003; 81 Suppl 3(15 Suppl 3): 38-47. doi: 10.2527/2003.81suppl_338x
Deb, R, Kumar, A, Chakraborty, S, et al. Trends in diagno-sis and control of bovine mastitis: A review. Pak J Biol Sci. 2013; 16(23): 1653-1661. doi: 10.3923/pjbs.2013.1653.1661
Dey D, Sharma B, Mondal, S, Nutritional approach to pre-vent mastitis of dairy cattle. Environment and Ecology. 2019; 37(1B): 344-348. https://www.cabidigitallibrary.org/doi/ pdf/10.5555/20193138424. Acccessed January 30, 2024.
Poindexter MB, Kweh MF, Zimpel R, et al. Feeding supplemen-tal 25-hydroxyvitamin D3 increases serum mineral concentrations and alters the mammary immunity of lactating dairy cows. J Dairy Sci. 2020; 103(1): 805-822. doi: 10.3168/jds.2019-16999
El-Sayed A, Kamel M, . Bovine mastitis prevention and control in the post-antibiotic era. Trop Anim Health Prod. 2021; 53: 236. doi: 10.1007/s11250-021-02680-9
Kashif M, Rizwan M, Ali M, Ahmad T, Durrani AZ. Control of mastitis through dry cow therapy: A review. Veterinaria, 2016; 4(2): 13-16. Website. https://thesciencepublishers.com/veterinar-ia/files/v4i2-3-2016008.pdf. Accessed January 30, 2024.
Ahmad T, Nadeem A, Saleem MI, Nadeem M, Saqib M. Con-trol of mastitis through dry cow therapy: A review. Sch Adv Anim Vet Res. 2015; 2: 128-135. Website. https://www.researchgate.net/ profile/Muhammad-Saleem-83/publication/341234271_Con-trol_of_Mastitis_Through_Dry_Cow_Therapy_A_Review/ links/5eb53630a6fdcc1f1dc8491e/Control-of-Mastitis-Through-Dry-Cow-Therapy-A-Review.pdf. Accessed January 30, 2024.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Veterinary Medicine (VM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
